Effectiveness and tolerability of low-dose oral oxycodone/naloxone added to anticonvulsant therapy for noncancer neuropathic pain: an observational analysis

Author： Lazzari M.   Sabato A. F.   Caldarulo C.   Casali M.   Gafforio P.   Marcassa C.   Leonardis F.  

Publisher： Informa Healthcare

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.30, Iss.4, 2014-04, pp. : 555-564

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Oral oxycodone/naloxone for pain control in cirrhosis: Observational study in patients with symptomatic metastatic hepatocellular carcinoma

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 38, Iss. 2, 2018-02 ,pp. : 278-284

John Wiley & Sons Inc

Access to resources Recommend Favorite

Fixed-ratio combination oxycodone/naloxone compared with oxycodone alone for the relief of opioid-induced constipation in moderate-to-severe noncancer pain

By Simpson K.   Leyendecker P.   Hopp M.   Müller-Lissner S.   Löwenstein O.   De Andrés J.   Troy Ferrarons J.   Bosse B.   Krain B.   Nichols T.   Kremers W.   Reimer K.  

Current Medical Research and Opinion, Vol. 24, Iss. 12, 2008-12 ,pp. : 3503-3512

Informa Healthcare

Access to resources Recommend Favorite

Oral oxycodone/naloxone for pain control in cirrhosis: Start slow, go slow

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 38, Iss. 2, 2018-02 ,pp. : 227-228

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effectiveness and Tolerability of a Moderate Dose of Tapentadol Prolonged Release for Managing Severe, Chronic Low Back Pain with a Neuropathic Component: An Open‐label Continuation Arm of a Randomized Phase 3b Study

By  

PAIN PRACTICE, Vol. 15, Iss. 5, 2015-06 ,pp. : 471-486

John Wiley & Sons Inc

Access to resources Recommend Favorite

Intravenous Lidocaine for Neuropathic Pain: A Retrospective Analysis of Tolerability and Efficacy

By  

PAIN MEDICINE, Vol. 16, Iss. 3, 2015-03 ,pp. : 531-536

John Wiley & Sons Inc

Access to resources Recommend Favorite